Skip to content

iRadimed IRMD Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin76.8%-0.1pp76.7%-0.2pp77.1%-0.1pp77%-0.2pp76.9%+0.3pp
Operating margin32.4%+2.3pp31.2%+1.2pp30.9%+1.0pp30.7%-0.2pp30.1%-0.6pp
Net margin27.4%+1.0pp26.8%+0.6pp26.3%+0.2pp26.6%-0.2pp26.3%-0.2pp
EBITDA margin34.1%+2.9pp32.6%+1.5pp32.1%+1.0pp31.7%31.2%
Free cash flow margin28.4%+8.9pp20.5%-3.6pp18.3%-6.6pp18.3%-1.2pp19.4%+2.6pp
Returns
Return on equity25%+1.2pp24.8%+0.5pp23.3%-0.3pp23.7%-1.3pp23.8%-1.7pp
Return on assets21.8%+1.0pp21.7%+1.5pp20.3%-0.2pp21%-0.7pp20.9%-1.1pp
Efficiency
Asset turnover0.8×0.0×0.8×0.0×0.8×0.0×0.8×0.0×0.8×0.0×
Inventory turnover1.7×+0.2×1.7×+0.3×1.6×+0.2×1.5×0.0×1.5×-0.2×
Liquidity
Current ratio7.1×-1.7×-0.9×6.6×-2.6×8.8×-1.1×8.9×-0.6×
Quick ratio6.1×-1.5×6.8×-0.8×5.7×-2.1×7.5×-0.7×7.6×-0.1×
Cash ratio4.7×-1.3×-1.1×4.4×-2.0×-0.5×5.9×0.0×
Per Share
Book value per share$7.65+9.0%$7.36+8.4%$7.65+17.1%$7.35+17.6%$7.02+17.6%
Valuation
Market capitalization$1.21B+62.0%$1.24B+77.5%$905.16M+42.1%$769.01M+38.2%$667.29M+19.8%
Price / earnings51.3×+13.5×55.1×+18.8×42.7×+8.5×37.2×+7.4×33.7×+2.6×
Price / sales14×+4.1×14.8×+5.2×11.2×+2.3×9.9×+1.9×8.9×+0.6×
Price / book12.2×+4.0×13.1×+5.1×9.2×+1.6×8.2×+1.2×7.4×+0.1×
Free cash flow yield2%+0.1pp1.4%-1.1pp1.6%-1.2pp1.8%-0.6pp2.2%+0.1pp
Earnings yield2%-0.7pp1.8%-0.9pp2.3%-0.6pp2.7%-0.7pp3%-0.3pp
Dividend yield1.3%+0.2pp1.2%0.9%
PEG ratio2.6×-1.0×3.3×+0.2×3.1×+0.7×3.4×+2.3×3.2×+2.2×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are iRadimed's profit margins?
iRadimed (IRMD) runs a 76.8% gross margin and a 32.4% operating margin, with a 27.4% net margin.
Where do iRadimed's ratios come from?
Every ratio is computed from iRadimed's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.